OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Update in migraine preventive treatment
Tzu‐Hsien Lai, Tzu-Chou Huang
Progress in brain research (2020), pp. 1-27
Closed Access | Times Cited: 6
Tzu‐Hsien Lai, Tzu-Chou Huang
Progress in brain research (2020), pp. 1-27
Closed Access | Times Cited: 6
Showing 6 citing articles:
International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine
Francesca Puledda, Simona Sacco, Hans‐Christoph Diener, et al.
Cephalalgia (2024) Vol. 44, Iss. 9
Closed Access | Times Cited: 14
Francesca Puledda, Simona Sacco, Hans‐Christoph Diener, et al.
Cephalalgia (2024) Vol. 44, Iss. 9
Closed Access | Times Cited: 14
Comparison of indirect treatment methods in migraine prevention to address differences in mode of administration
Christopher G. Fawsitt, Howard Thom, Stephane A. Régnier, et al.
Journal of Comparative Effectiveness Research (2023) Vol. 12, Iss. 7
Open Access | Times Cited: 4
Christopher G. Fawsitt, Howard Thom, Stephane A. Régnier, et al.
Journal of Comparative Effectiveness Research (2023) Vol. 12, Iss. 7
Open Access | Times Cited: 4
Safety Profile of Botulinum Toxin for Migraine Headache Prophylaxis: A Systematic Review and Meta-analysis
Mohaddeseh Azadvari, Maryam Hosseini, Seyede Zahra Emami Razavi, et al.
Annals of Military and Health Sciences Research (2023) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Mohaddeseh Azadvari, Maryam Hosseini, Seyede Zahra Emami Razavi, et al.
Annals of Military and Health Sciences Research (2023) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Improved quality of life with fremanezumab in Japanese and Korean patients with episodic and chronic migraine: Results of two multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group clinical trials
Yasuhiko Matsumori, Miki Ishida, Katsuhiro Iba, et al.
Headache The Journal of Head and Face Pain (2023) Vol. 63, Iss. 9, pp. 1304-1313
Open Access
Yasuhiko Matsumori, Miki Ishida, Katsuhiro Iba, et al.
Headache The Journal of Head and Face Pain (2023) Vol. 63, Iss. 9, pp. 1304-1313
Open Access
Effects of Anti-CGRP monoclonal antibodies for episodic and chronic migraine on migraine characteristics, disability, impact and quality of life beyond 3 months of treatment: A Systematic review and Meta-analysis
Oxana Grosu, Nooshin Yamani, Nathaniel M. Schuster, et al.
Headache Medicine Connections (2021) Vol. 1, Iss. 2, pp. 23-30
Open Access
Oxana Grosu, Nooshin Yamani, Nathaniel M. Schuster, et al.
Headache Medicine Connections (2021) Vol. 1, Iss. 2, pp. 23-30
Open Access
Calcitonin-Gene-Related Peptide (CGRP) Monoclonal Antibodies in Migraine Prevention; Literature Review
Haneen Ahmed Khouja, Rawan Awadh Alshehri, Hussain Mirza Alhalal, et al.
World Journal of Environmental Biosciences (2021) Vol. 10, Iss. 1, pp. 48-51
Open Access
Haneen Ahmed Khouja, Rawan Awadh Alshehri, Hussain Mirza Alhalal, et al.
World Journal of Environmental Biosciences (2021) Vol. 10, Iss. 1, pp. 48-51
Open Access
